Some patients report mild queasiness managed with ginger tea or small sips of water, while others feel stronger nausea requiring dietary adjustment and rest
Here's what it takes for me to bother
Due to the drug makers failure to adequately disclose these risks on the drug label, at least 1,331 Ozempic lawsuits, Wegovy lawsuits and other complaints naming different GLP-1 drugs, have been filed in federal courts against Novo Nordisk and Eli Lilly, each raising allegations that the drug manufacturers prioritized profits over consumer safety by withholding critical safety information from users and the medical community about the risk of serious gastroparesis side effects
Track your weight, appetite, and menstrual cycle regularity during the washout period to ensure your metabolism is normalizing
Thirdly, gastrointestinal effects represent another consideration
WADA is watching closely The World Anti-Doping Agency (WADA) added semaglutide (a GLP-1 RA) to its 2024 Monitoring Program